Andrew X. Zhu - Researcher Profile | RDL Research Database

Publications

2 shown

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero , Laura Kulik , Claude B. Sirlin +5 more

Marrero, Jorge A.; Kulik, Laura M.; Sirlin, Claude B.; Zhu, Andrew X.; Finn, Richard S.; Abecassis, Michael M.; Roberts, Lewis R.; Heimbach, Julie K. Author Information

2018 Hepatology 4379 citations

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 10,843
Institution: Harvard University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-4873-5033

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.